Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...

A CDC panel is reconsidering the birth dose for the hepatitis B vaccine. Renewed doubt could lead to fewer kids getting ...

Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...

Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after starting his new role, in a major setback for Commissioner Marty Makary.

Kirk Milhoan has claimed without evidence that the covid-19 shots caused spikes in cancer and miscarriages. Now he's helping ...

A confidential internal memo from the U.S. Food and Drug Administration (FDA) is creating new controversy around vaccine ...

With no evidence to support the claim that 10 children died due to COVID-19 vaccines, experts unpack the impact of CBER chief ...

The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

FDA moves reshaping drug policy include fast-track programs, updated biosimilar guidance, and new rare disease approval pathways.

Rick Pazdur had clashed with Trump officials on the legality and pace of their initiatives. He could still withdraw his ...

As vaccine policy uncertainty reaches a new level in the U.S., the Centers for Disease Control and Prevention's (CDC’s) team ...